Reanalysis of the Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children < 5 Age...

por Li, Xiuyan, Warren, Sophie, Rozenbaum, Mark H., Perdrizet, Johnna
Publicado 2023

The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review

por Vondeling, Gerard T., Cao, Qi, Postma, Maarten J., Rozenbaum, Mark H.
Publicado 2018

Annual Cardiovascular-Related Hospitalization Days Avoided with Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy

por Rozenbaum, Mark H., Tran, Diana, Bhambri, Rahul, Nativi-Nicolau, Jose
Publicado 2022

Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States

por Rozenbaum, Mark H., Judy, Jen, Tran, Diana, Yacisin, Kari, Kurosky, Samantha K., Begier, Elizabeth
Publicado 2023

An update of “Cost-effectiveness of rotavirus vaccination in the Netherlands: the results of a Consensus Rotavirus Vaccine model”

por Tu, Hong Anh T, Rozenbaum, Mark H, de Boer, Pieter T, Noort, Albert C, Postma, Maarten J
Publicado 2013

Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world

por Postma, Maarten J, Jit, Mark, Rozenbaum, Mark H, Standaert, Baudouin, Tu, Hong-Anh, Hutubessy, Raymond CW
Publicado 2011

Economic Evaluation of Apixaban for the Prevention of Stroke in Non-Valvular Atrial Fibrillation in the Netherlands

por Stevanović, Jelena, Pompen, Marjolein, Le, Hoa H., Rozenbaum, Mark H., Tieleman, Robert G., Postma, Maarten J.
Publicado 2014

Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model

por Rozenbaum, Mark H, Mangen, Marie-Josee J, Giaquinto, Carlo, Wilschut, Jan C, Hak, Eelko, Postma, Maarten J
Publicado 2011

Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis

por Rozenbaum, Mark H, van Hoek, Albert Jan, Fleming, Douglas, Trotter, Caroline L, Miller, Elizabeth, Edmunds, W John
Publicado 2012

A Response to: Letter to the Editor Regarding ‘Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate...

por Rozenbaum, Mark H., Perdrizet, Johnna, Li, Xiuyan, Wasserman, Matt D., Grant, Lindsay R., Hayford, Kyla, Farkouh, Raymond A.
Publicado 2022

Incidence of Respiratory Syncytial Virus Infection in Older Adults: Limitations of Current Data

por Rozenbaum, Mark H., Begier, Elizabeth, Kurosky, Samantha K., Whelan, Jo, Bem, Danai, Pouwels, Koen B., Postma, Maarten, Bont, Louis
Publicado 2023

Assessing the value of orphan drugs using conventional cost-effectiveness analysis: Is it fit for purpose?

por Postma, Maarten J., Noone, Declan, Rozenbaum, Mark H., Carter, John A., Botteman, Marc F., Fenwick, Elisabeth, Garrison, Louis P.
Publicado 2022

The impact of patent expiry on drug prices: insights from the Dutch market

por van der Schans, Simon, Vondeling, Gert T., Cao, Qi, van der Pol, Simon, Visser, Sipke, Postma, Maarten J., Rozenbaum, Mark H.
Publicado 2020

Impact of Delayed Diagnosis and Misdiagnosis for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM): A Targeted Literature Review

por Rozenbaum, Mark H., Large, Samuel, Bhambri, Rahul, Stewart, Michelle, Whelan, Jo, van Doornewaard, Alexander, Dasgupta, Noel, Masri, Ahmad, Nativi-Nicolau, Jose
Publicado 2021

Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the open-l...

por Rozenbaum, Mark H, Garcia, Andrea, Grima, Daniel, Tran, Diana, Bhambri, Rahul, Stewart, Michelle, Li, Benjamin, Heeg, Bart, Postma, Maarten, Masri, Ahmad
Publicado 2021

Is Adding HCV Screening to the Antenatal National Screening Program in Amsterdam, The Netherlands, Cost-Effective?

por Urbanus, Anouk T., van Keep, Marjolijn, Matser, Amy A., Rozenbaum, Mark H., Weegink, Christine J., van den Hoek, Anneke, Prins, Maria, Postma, Maarten J.
Publicado 2013

Estimating the Impact of Switching from a Lower to Higher Valent Pneumococcal Conjugate Vaccine in Colombia, Finland, and The Netherlands: A Cost-Effectiveness Analysis

por Pugh, Sarah, Wasserman, Matt, Moffatt, Margaret, Marques, Susana, Reyes, Juan Manuel, Prieto, Victor A., Reijnders, Davy, Rozenbaum, Mark H., Laine, Juha, Åhman, Heidi, Farkouh, Raymond
Publicado 2020

Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden

por Lauppe, Rosa Elisabeth, Liseth Hansen, Johan, Gerdesköld, Christian, Rozenbaum, Mark H, Strand, Anne Mette, Vakevainen, Merja, Kuusisto, Johanna, Gude, Einar, Gustafsson, Finn, Smith, J Gustav
Publicado 2021

Healthcare resource use of patients with transthyretin amyloid cardiomyopathy

por Lauppe, Rosa, Liseth Hansen, Johan, Fornwall, Anna, Johansson, Katarina, Rozenbaum, Mark H., Strand, Anne Mette, Vakevainen, Merja, Kuusisto, Johanna, Gude, Einar, Smith, J. Gustav, Gustafsson, Finn
Publicado 2022

Prevalence, characteristics, and mortality of patients with transthyretin amyloid cardiomyopathy in the Nordic countries

por Lauppe, Rosa, Liseth Hansen, Johan, Fornwall, Anna, Johansson, Katarina, Rozenbaum, Mark H., Strand, Anne Mette, Väkeväinen, Merja, Kuusisto, Johanna, Gude, Einar, Smith, J. Gustav, Gustafsson, Finn
Publicado 2022